Nav: Home

Crumpled graphene makes ultra-sensitive cancer DNA detector

March 24, 2020

CHAMPAIGN, Ill. -- Graphene-based biosensors could usher in an era of liquid biopsy, detecting DNA cancer markers circulating in a patient's blood or serum. But current designs need a lot of DNA. In a new study, crumpling graphene makes it more than ten thousand times more sensitive to DNA by creating electrical "hot spots," researchers at the University of Illinois at Urbana-Champaign found.

Crumpled graphene could be used in a wide array of biosensing applications for rapid diagnosis, the researchers said. They published their results in the journal Nature Communications.

"This sensor can detect ultra-low concentrations of molecules that are markers of disease, which is important for early diagnosis," said study leader Rashid Bashir, a professor of bioengineering and the dean of the Grainger College of Engineering at Illinois. "It's very sensitive, it's low-cost, it's easy to use, and it's using graphene in a new way."

While the idea of looking for telltale cancer sequences in nucleic acids, such as DNA or its cousin RNA, isn't new, this is the first electronic sensor to detect very small amounts, such as might be found in a patient's serum, without additional processing.

"When you have cancer, certain sequences are overexpressed. But rather than sequencing someone's DNA, which takes a lot of time and money, we can detect those specific segments that are cancer biomarkers in DNA and RNA that are secreted from the tumors into the blood," said Michael Hwang, the first author of the study and a postdoctoral researcher in the Holonyak Micro and Nanotechnology Lab at Illinois.

Graphene - a flat sheet of carbon one atom thick - is a popular, low-cost material for electronic sensors. However, nucleic-acid sensors developed so far require a process called amplification - isolating a DNA or RNA fragment and copying it many times in a test tube. This process is lengthy and can introduce errors. So Bashir's group set out to increase graphene's sensing power to the point of being able to test a sample without first amplifying the DNA.

Many other approaches to boosting graphene's electronic properties have involved carefully crafted nanoscale structures. Rather than fabricate special structures, the Illinois group simply stretched out a thin sheet of plastic, laid the graphene on top of it, then released the tension in the plastic, causing the graphene to scrunch up and form a crumpled surface.

They tested the crumpled graphene's ability to sense DNA and a cancer-related microRNA in both a buffer solution and in undiluted human serum, and saw the performance improve tens of thousands of times over flat graphene.

"This is the highest sensitivity ever reported for electrical detection of a biomolecule. Before, we would need tens of thousands of molecules in a sample to detect it. With this device, we could detect a signal with only a few molecules," Hwang said. "I expected to see some improvement in sensitivity, but not like this."

To determine the reason for this boost in sensing power, mechanical science and engineering professor Narayana Aluru and his research group used detailed computer simulations to study the crumpled graphene's electrical properties and how DNA physically interacted with the sensor's surface.

They found that the cavities served as electrical hotspots, acting as a trap to attract and hold the DNA and RNA molecules.

"When you crumple graphene and create these concave regions, the DNA molecule fits into the curves and cavities on the surface, so more of the molecule interacts with the graphene and we can detect it," said graduate student Mohammad Heiranian, a co-first author of the study. "But when you have a flat surface, other ions in the solution like the surface more than the DNA, so the DNA does not interact much with the graphene and we cannot detect it."

In addition, crumpling the graphene created a strain in the material that changed its electrical properties, inducing a bandgap - an energy barrier that electrons must overcome to flow through the material - that made it more sensitive to the electrical charges on the DNA and RNA molecules.

"This bandgap potential shows that crumpled graphene could be used for other applications as well, such as nano circuits, diodes or flexible electronics," said Amir Taqieddin, a graduate student and coauthor of the paper.

Even though DNA was used in the first demonstration of crumpled graphene's sensitivity for biological molecules, the new sensor could be tuned to detect a wide variety of target biomarkers. Bashir's group is testing crumpled graphene in sensors for proteins and small molecules as well.

"Eventually the goal would be to build cartridges for a handheld device that would detect target molecules in a few drops of blood, for example, in the way that blood sugar is monitored," Bashir said. "The vision is to have measurements quickly and in a portable format."
-end-
The National Science Foundation supported this work through the Illinois Materials Research Science and Engineering Center.

Editor's notes: To reach Rashid Bashir, email rbashir@illinois.edu. To reach Narayan Aluru, call 217-333-1180; email aluru@illinois.edu. To reach Michael Hwang, email mth@illinois.edu.

The paper "Ultrasensitive detection of nucleic acids using deformed graphene channel field effect biosensors" is available from press@nature.com.

University of Illinois at Urbana-Champaign, News Bureau

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.